The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)

Leopold Streletz, J. Cracco

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Although no therapeutic agent has proved to be of benefit in subacute sclerosing panencephalitis (SSPE), the use of Isoprinosine has been associated with clinical improvement in several preliminary reports. Two additional patients with SSPE are presented who had repeated serological and electroencephalographic studies during therapy with Isoprinosine. Their clinical courses are discussed in view of the laboratory findings and the natural history of the disease.

Original languageEnglish
Pages (from-to)183-184
Number of pages2
JournalAnnals of Neurology
Volume1
Issue number2
DOIs
Publication statusPublished - 1977
Externally publishedYes

Fingerprint

Inosine Pranobex
Subacute Sclerosing Panencephalitis
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Neurology
  • Clinical Neurology

Cite this

The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE). / Streletz, Leopold; Cracco, J.

In: Annals of Neurology, Vol. 1, No. 2, 1977, p. 183-184.

Research output: Contribution to journalArticle

@article{3acf192574df4fe4afcb86a705504280,
title = "The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)",
abstract = "Although no therapeutic agent has proved to be of benefit in subacute sclerosing panencephalitis (SSPE), the use of Isoprinosine has been associated with clinical improvement in several preliminary reports. Two additional patients with SSPE are presented who had repeated serological and electroencephalographic studies during therapy with Isoprinosine. Their clinical courses are discussed in view of the laboratory findings and the natural history of the disease.",
author = "Leopold Streletz and J. Cracco",
year = "1977",
doi = "10.1002/ana.410010214",
language = "English",
volume = "1",
pages = "183--184",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE)

AU - Streletz, Leopold

AU - Cracco, J.

PY - 1977

Y1 - 1977

N2 - Although no therapeutic agent has proved to be of benefit in subacute sclerosing panencephalitis (SSPE), the use of Isoprinosine has been associated with clinical improvement in several preliminary reports. Two additional patients with SSPE are presented who had repeated serological and electroencephalographic studies during therapy with Isoprinosine. Their clinical courses are discussed in view of the laboratory findings and the natural history of the disease.

AB - Although no therapeutic agent has proved to be of benefit in subacute sclerosing panencephalitis (SSPE), the use of Isoprinosine has been associated with clinical improvement in several preliminary reports. Two additional patients with SSPE are presented who had repeated serological and electroencephalographic studies during therapy with Isoprinosine. Their clinical courses are discussed in view of the laboratory findings and the natural history of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0017451999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017451999&partnerID=8YFLogxK

U2 - 10.1002/ana.410010214

DO - 10.1002/ana.410010214

M3 - Article

VL - 1

SP - 183

EP - 184

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -